改善管理前PPQ生物产品知识的机会
Beth Fulton1, Theo Zacharatos2, Igor Gorsky3
1QRM Consultant, ValSource Inc., USA bfulton@valsource.com.
PDA journal of pharmaceutical science and technology
|October 16, 2025
概括
有效的知识管理 (KM) 对生物药品质量至关重要. 本文介绍了CQA知识可访问性维护循环 (CQA-KAML),用于在过程性能合格 (PPQ) 之前管理关键质量属性知识.
科学领域:
- 制药制造业 制药制造业 制药制造业
- 生物学的发展 生物学的发展
- 知识管理系统知识管理系统
背景情况:
- 知识管理 (KM) 对于在整个生命周期中保持生物药物产品质量至关重要.
- 需要有效的KM策略,特别是在过程前的性能合格 (PPQ) 阶段.
- 当前的做法可能无法充分捕捉或利用关键质量属性 (CQA) 知识.
研究的目的:
- 在PPQ之前,提出生物制造组织知识管理的结构化方法.
- 引入关键质量属性知识可访问性维护循环 (CQA-KAML) 概念.
- 将知识管理实践与监管期望保持一致,例如ICH Q10.
主要方法:
- 这篇论文提出了生命周期知识管理的概念框架.
- 它结合了2024年PDA年度会议上的演讲的见解.
- 使用实时观众反来定制KM建议.
主要成果:
- 引入了一个新的生命周期知识管理概念,CQA-KAML.
- 该框架有助于识别和管理与CQA相关的知识.
- 该方法旨在提高知识的可访问性和从早期发展阶段保留知识.
结论:
- 实施CQA-KAML可以改善生物药物开发的知识管理.
- 在PPQ之前积极的KM对于确保产品质量和监管合规至关重要.
- CQA-KAML提供了一种系统的方法,以与ICH Q10等指南保持一致.
相关概念视频
Drug Products: Biologics, Biosimilars and Interchangeables
230
Body:Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
230
Biopharmaceutics and Pharmacokinetics: Overview
3.3K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
3.3K
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
177
Body:Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug...
177
Preclinical Development: Overview
5.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.8K
Biopharmaceutical Factors Influencing Drug Product Design: Overview
232
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
232
Methods of Documentation II: POMR
1.4K
The Problem-Oriented Medical Record (POMR) revolutionized medical record-keeping by introducing a systematic approach focusing on the patient's problems rather than merely listing symptoms. Dr. Lawrence Weed's introduction of this method in the 1960s marked a significant advancement in medical documentation. The POMR framework consists of four key components: the database, problem list, plan of care, and progress notes.
1.4K


